This is a pilot randomized control trial randomizing patients presenting in opioid withdrawal to the emergency department to receive either one of clonidine (usual standard of care) or buprenorphine for their opioid withdrawal. Primary treatment outcome is attendance at a rapid access addiction medicine clinic within a few days of emergency room presentation. Secondary treatment outcome is treatment status with respect to opioid agonist treatment at one month post emergency room visit.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
26
The participant receives buprenorphine
The participant receives clonidine
Number of participants attending the rapid access clinic
The number of participants who attend a rapid access clinic assessment after initial enrollment
Time frame: 2-5 days
Number of participants who are on opioid agonist treatment
The number of participants who are maintained on some form of opioid agonist treatment at the one-month mark
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.